Additionally, stromal cells in the MM tumor microenvironment help MM cells develop drug resistance and prolong MM cell survival, but we found that nanoencapsulated BTZ and BCMA-targeted BTZ-NP therapy could overcome this effect of the stromal microenvironment. The gene discussed is TNFRSF17; the disease is neoplasm.